| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| VL Vincent Leva Linden Advisors LP | 594,637 | $3,448.89 | $9,989.9 | $6,541.01 | 189.66% |
| BO Brian Oliveira Clear Street Group Inc. | 199,370 | $1,160.17 | $2,651.62 | $1,491.45 | 128.55% |
| ECM Eisler Capital Management Ltd. Eisler Capital Management Ltd. | 10,931 | $276 | $145.38 | -$130.62 | -47.33% |
| Biotechnology Industry | Healthcare Sector | Alejandro Antalich CEO | NASDAQ (CM) Exchange | G6223S117 CUSIP |
| KY Country | 52 Employees | - Last Dividend | 3 Jan 2023 Last Split | 3 Jan 2023 IPO Date |
Moolec Science SA is a pioneering science-based food ingredient company, established in 2020 and headquartered in Luxembourg. It specializes in creating real animal proteins within plants through a revolutionary approach known as molecular farming. This technique allows Moolec Science to produce animal proteins efficiently and sustainably, without needing to harvest the animals themselves. The company has a robust footprint, operating across the United States, Europe, and South America, reflecting its global approach to addressing the needs of the food industry and contributing to food sustainability efforts.